792 Million Newborns, 1.4 Trillion Yuan of Spend: What Actually Sells in China's Baby & Maternal Market Now

The data floor: fewer babies, heavier wallets

(And the demographic floor may be near: H1 2026 births are tracking roughly −5% YoY, a gentler decline than the post-Dragon-year drop of 2025.)

The formula market's headline "zero-sum" framing hides a barbell. Regular cow-milk formula declined ~2%; goat-milk formula −12.2%; but specialty formula (allergy, premature, hypoallergenic) grew +5.2%, premium ultra-high-end lines are the stated growth engine of every leading player, and organic claims have carried brands to counter-cyclical records — Bellamy's grew 20%+ in 2025 and has led cross-border organic formula for eight consecutive years.

What this means: the three shifts that define entry now

1. From volume to verification.

Chinese parents' infant purchases are made with near-zero error tolerance — the category runs on safety memory (2008 melamine still shapes behavior) and document-level scrutiny. The 2026 environment adds another layer: national subsidies and a state push for "child-friendly" consumption channels more spending through verified retail — official stores, platform trust programs, instant-retail partnerships with national chains — not through gray channels. For imported brands, this is favorable: it formalizes exactly the trust infrastructure (traceability, certification, official flagship presence) that legitimate foreign brands build best.

2. From milk powder to the full parental wallet.

The modern reading of "baby & maternal" is a household-level premium basket: maternal nutrition during pregnancy, postpartum recovery, baby skincare and personal care (the "safety-first" personal care sub-category where imported brands over-index), baby hardware, and early-life supplements. Formula is the trust anchor — the category through which a parent learns whether your brand keeps promises — but the margin and differentiation often live in the adjacencies. A Western brand entering with maternity nutrition or baby skincare (not formula) gets the same trust-transfer dynamics with far lighter regulatory load.

3. From stores to speed-plus-trust hybrid channels.

Instant retail (Meituan flash-purchase, JD seconds-delivery) is becoming the top incremental channel for mother-and-baby staples — Meituan's mother-and-baby GTV grew 42% in Q1 2026, with formula and diapers 78% of it. What this changes is fulfillment expectations, not the trust decision: parents still research on Xiaohongshu and verify in official marketplaces; they now expect replenishment in under an hour. For cross-border entrants this matters as a design constraint — your cross-border SKUs (bonded-warehouse fulfilled, 2–5 days) should carry the considered first purchase, while repeat replenishment expectations must be planned into your channel mix (including eventual domestic distribution for proven SKUs).

Where imported brands actually win, category by category

• Organic and premium formula (cross-border): the strongest structural lane — organic certification is hard to fake, resonates with the safety hierarchy, and Bellamy's-style cross-border organic leadership persists. Constraint: cross-border formula purchases are limited by quota mechanics and platform rules; treat it as a beachhead, with registration as the scaling path.
• Specialty formula: +5.2% growth, but requires registration and clinical positioning — a year-3 play for entrants who have proven demand.
• Maternal nutrition and postpartum: chronically under-served by domestic brands on trust; cross-border supplements and maternal skincare enter with the lightest regulatory load and the highest perceived-safety transfer.
• Baby skincare and personal care: the safety-first instinct is at its strongest; imported brands over-index here, and claims discipline (no medical claims for infant products) is the main compliance work.
• Baby hardware (strollers, monitors, feeding systems): premium price points now fit the raised CNY 8,000 cross-border order limit; trust-heavy, registration-light — a natural first category.

What this means for a $50-100M brand

• Do not model China on 2015 demographics — or 2015 prices. The market you are entering is smaller in babies but richer per baby and more brand-concentrated in trust. Plan for share-of-wallet economics, not population tailwinds.
• Lead with the safest, most verifiable wedge you own. Organic certification, clinical heritage, or a pharmacy-grade reputation translates directly; "nice design at a good price" does not — the middle of this market is collapsing.
• Expect and exploit subsidy tailwinds. The 2026 subsidy rollout is a demand floor for baby categories, especially in lower-tier cities — but it flows through formal channels, reinforcing the official-store-first strategy.
• Sequence: trust anchor → adjacency expansion. Enter with the single most verifiable category you have; expand into the household basket once the first promise has been kept at scale.

Our take

The brands still winning in China's baby market share one pattern: they treated the demographic decline not as a reason to stay out but as a filter that removed their weakest competitors — the ones who needed volume to work. What remains is the highest-spend-per-child consumer base in the world, shopping through formalizing channels that reward exactly what legitimate foreign brands are best at: documentation, traceability, and restraint in claims. If we were placing a mid-sized Western baby/maternal brand today: enter cross-border with an organic-or-clinical wedge (formula if you can carry the weight, maternal nutrition or baby skincare if you want speed), anchor trust in an official flagship, build the Xiaohongshu research layer where new parents now live, and hold registration as a year-2/3 scaling decision. Fewer babies; more conviction. That's the market.

Sources

1. National Bureau of Statistics of China — births and birth rate, 2025; retail context, 2026.
2. Frost & Sullivan — 0–3 child population, 2020–2025.
3. NielsenIQ — formula market performance and household spend share, 2025–2026.
4. Company disclosures and trade coverage (China Ausnutrie/Bellamy's, China Feihe, Yili, Mead Johnson) — category performance and premiumization, 2025–2026.
5. State Council (2025) childcare-support measures and 2026 provincial subsidy implementations; Meituan Q1 2026 disclosures (instant retail).
6. Industry estimates — infant formula market size, 2025–2026.
7. Resonate Consulting analysis.

Disclaimer: This article draws on a wide range of industry research reports and publicly available sources. If any content infringes upon the intellectual property rights of any individual or organization, please contact us promptly and we will address it immediately.